EIBIR is excited to present a series of Bonus Sessions at ECR 2026, showcasing the latest advances in medical imaging, AI, and cancer research.
Session Schedule:
EIBIR 1 – Wednesday, March 4, 2026 | 11:30–12:30
Explore how real-world data is shaping lung cancer screening through SOLACE’s 25,000-participant records, national quality certification programs, anonymization advances from ChAImeleon to EUCAIM, data warehouse maturity across European hospitals, and socio-environmental certification pathways.
EIBIR 2 – Thursday, March 5, 2026 | 11:30–12:30
Innovative applications in imaging including CEST MRI for thyroid disease, contrast-driven exposure control in cardiac imaging, AI-based MS lesion detection, photoacoustic imaging enhanced by deep learning, delta-radiomics for breast cancer prediction, and AI’s transformative role in interventional radiology.
🏅 This session features EIBIR Award Winner Ms. Sumana Halder (India).
EIBIR 3 –Thursday, March 5, 2026 | 15:00–16:00
AI applications transforming cancer care: foundation models for rare neurodegenerative disorders, radiomics distinguishing benign vs malignant tumors, digital twins for breast cancer risk monitoring, CNNs for lung emphysema detection, AI-driven liver segmentation for brachytherapy, and foundation models for rectal cancer T-staging.
EIBIR 4b – Friday, March 6, 2026 | 14:00–15:00
Advances in AI-powered cancer imaging including vertebral fracture detection on chest X-rays, immunotherapy response prediction, prostate lesion segmentation with LSTM models, explainable radiomics for breast cancer diagnosis, and multimodal AI integrating imaging and omics data for personalized oncology.
📍 All sessions will take place only onsite at the EIBIR Booth (Level 1).
These sessions provide a unique opportunity to explore groundbreaking research, learn from leading experts, and experience innovative technologies in action.